EN
登录

加拿大诺华公司启动50万美元资助计划,以改善加拿大的健康公平

Novartis Canada launches $500,000 funding initiative to improve health equity in Canada

BioSpace 等信源发布 2024-07-08 20:48

可切换为仅中文


MONTRÉAL, July 8, 2024 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) today announced the launch of a new health equity initiative, aimed at addressing health disparities and promoting equitable healthcare for Canadians. In this open call for ideas, Novartis will award $500,000 CAD to non-profit projects focused on improving health equity in three pivotal areas: social/cultural inclusivity of care, health literacy and education, and the promotion of health support for immigrants to Canada..

。在这次公开征集意见的活动中,诺华将向非营利项目提供50万加元,这些项目的重点是改善三个关键领域的健康公平性:护理的社会/文化包容性、健康素养和教育,以及促进对加拿大移民的健康支持。。

Despite a publicly funded healthcare system, access to timely and appropriate care still is challenging for many individuals in Canada.1 Novartis is committed to changing this by funding innovative ideas and approaches that challenge the status quo and improve the overall health and well-being of Canadians.

尽管有公共资助的医疗保健系统,但对于加拿大的许多人来说,获得及时和适当的护理仍然是一个挑战。1诺华致力于通过资助挑战现状并改善加拿大人整体健康和福祉的创新想法和方法来改变这一现状。

Improving health equity requires reducing socioeconomic disparities, promoting culturally sensitive care, enhancing access to health services and addressing the specific needs of marginalized populations..

改善卫生公平需要减少社会经济差异,促进对文化敏感的护理,增加获得卫生服务的机会,并解决边缘化人群的具体需求。。

'Our commitment extends beyond the traditional boundaries of healthcare, and we are working with underserved groups, non-profit organizations and communities to deliver meaningful and sustainable change within Canadian society,' says Mark Vineis, Country President Novartis Canada. 'By embracing the power of cross-sector collaboration, we can create a paradigm shift towards a more inclusive and equitable healthcare system for all Canadians.'.

诺华加拿大公司总裁马克·维尼斯(Mark Vineis)说:“我们的承诺超越了医疗保健的传统界限,我们正在与服务不足的团体、非营利组织和社区合作,为加拿大社会带来有意义和可持续的变革。”通过拥抱跨部门合作的力量,我们可以为所有加拿大人创造一个更具包容性和公平的医疗体系的范式转变。”。

To build skills and capacity to develop the Novartis Health Equity Initiative, Novartis consulted and received training from Equity Mobilizing Partnerships in Community (EMPaCT) an innovative, award-winning model of patient and community engagement housed at Women's College Hospital, Toronto, Canada.

为了培养发展诺华健康公平倡议的技能和能力,诺华咨询并接受了社区公平动员伙伴关系(EMPaCT)的培训,这是一种创新的,屡获殊荣的患者和社区参与模式,位于加拿大多伦多女子学院医院。

Through a series of upskilling workshops, EMPaCT instructed on key concepts and practices identified as critical to run a successful health equity-focused community investment program, and to orient and equip staff on the competencies to design an inclusive grant program. EMPaCT acts as a catalyst for positive change by providing timely recommendations to projects so that they can increase health equity..

。EMPaCT通过向项目提供及时的建议来促进积极的变化,从而提高健康公平性。。

In a collective statement, the co-founders of EMPaCT, scientist Dr. Ambreen Sayani and patient partner Alies Maybee, commented that, 'we need to include diverse people with a variety of lived/living experiences to create meaningful change in our society.'

在一份集体声明中,EMPaCT的联合创始人、科学家Ambreen Sayani博士和患者合作伙伴Alies Maybee评论说,“我们需要包括拥有各种生活/生活经历的不同人群,以在我们的社会中创造有意义的变化。”

How to apply for funding

如何申请资金

Novartis Canada warmly welcomes all organizations that share their passion for advancing health equity to apply for funding and is committed to uniting and leading a paradigm shift towards a more inclusive and fair healthcare system – one that benefits every individual in Canada.

诺华加拿大公司热烈欢迎所有对促进健康公平有共同热情的组织申请资金,并致力于团结和领导向更具包容性和公平的医疗体系的范式转变-一个惠及加拿大每个人的医疗体系。

To find out more information about the initiative and apply for funding, please visit https://www.novartis.com/ca-en/esg/novartis-health-equity-initiative. All applications must be received before 11:59 p.m. PT on September 15, 2024.

要了解有关该计划的更多信息并申请资金,请访问https://www.novartis.com/ca-en/esg/novartis-health-equity-initiative.所有申请必须在2024年9月15日下午11:59之前收到。

About Novartis

关于诺华

Novartis is a focused innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram..

诺华是一家专注于创新药物的公司。每天,我们都在努力重新设计医学,以改善和延长人们的生活,从而使患者、医疗保健专业人员和社会在面对严重疾病时获得权力。我们的药物惠及全球2.5亿多人。与我们一起重新想象医学:访问我们https://www.novartis.com并通过LinkedIn、Facebook、X/Twitter和Instagram与我们联系。。

In Canada, Novartis Pharmaceuticals Canada Inc. employs approximately 600 people to serve the evolving needs of patients and the healthcare system and invests over $30 million in R&D yearly in the country. For more information visit www.novartis.ca.

在加拿大,诺华制药加拿大公司雇用了大约600名员工,以满足患者和医疗保健系统不断变化的需求,每年在该国的研发投资超过3000万美元。有关更多信息,请访问www.novartis.ca。

MLR ID FA-11223687

MLR ID FA-11223687

References

参考文献

_________________________________

_________________________________

1 Statistics Canada, 2023. Access to health care.

1加拿大统计局,2023年。获得医疗保健。

SOURCE Novartis Pharmaceuticals Canada Inc.

来源:加拿大诺华制药有限公司。